baber/WOPTO huggingface dataset:
Patent DE-69129929-T2 (DE)
Inventor: TSURUOKA SHINSUKE
IPC: H04N1/407
Filed: 1991-09-23
Granted: 1999-01-14
Abstract: A print evaluating apparatus includes an image reader having a plurality of photoreceptors to read a print pattern line by line; relative movement causing device for imparting relative movement between the print pattern and the image reader in a direction different from a direction in which the photoreceptors are arranged; and a processor for effecting plural operations in parallel for plural evaluation items for image signals corresponding to the print pattern supplied by the image reader during the relative movement, and for effecting evaluation on data provided by the operations.
Patent DE-69131963-T2 (DE)
Inventor: LU PANG-CHIA
IPC: A61L15/58
Filed: 1991-11-12
Granted: 2000-10-05
Abstract: A composite material comprising a base liner with a release layer on at least one surface thereof, and a releasable face layer releasably adhered to the base liner through the release layer by a pressure sensitive adhesive, wherein the base liner has a skin layer on its surface proximate to the release layer which is more difficult to cut than the remainder of the base liner material, such that when the composite is subjected to die cutting or perforating to allow portions of the face layer to be selectively removed, the cutter will not penetrate into or through the base liner to any substantial extent.
Patent DE-69133006-T2 (DE)
Inventor: MILLER PHILLIP C
IPC: G01N1/30
Filed: 1991-02-27
Granted: 2002-12-12
Abstract: The present invention provides an improved method for staining slides using immunochemical reagents. The method comprises the following steps. The assay region of a slide (the region containing the tissue section) is washed with an improved rinsing solution comprising water and a detergent. An evaporation inhibitor liquid is applied to the slide to cover the assay region. For antigens requiring unmasking, the tissue section is combined with an improved, stabilized proteolytic enzyme solution. The slide is rinsed, and the evaporation inhibitor liquid is reapplied to the slide. A primary antibody in an improved diluent containing globulins from the same species as a second antibody is combined with the tissue section for a time sufficient to substantially complete antibody binding. The slide is rinsed, and the evaporation inhibitor liquid is reapplied. A labeled second antibody in the improved diluent is combined with the tissue section for a time sufficient for substantially complete antibody binding. The slide is rinsed, and the evaporation inhibitor liquid is reapplied to the slide. Color development reagents, including, in a preferred embodiment, a stabilized diaminobenzidine (DAB) solution, are combined with the tissue section for a time sufficient for color development. Following rinsing, the tissue section is ready for analysis.
Patent DE-69201833-T2 (DE)
Inventor: SELLERS CHARLES
IPC: B65H3/44
Filed: 1992-01-30
Granted: 1995-10-26
Abstract: A dual bin envelope tray is adapted to support, in a side-by-side relationship, two stacks of envelopes which may be of different sizes. The envelope tray is configured to be interchangeable with the conventional paper supply tray of a printing device, such as a printer, copier or the like, and may be inserted directly into the printing device housing opening from which the paper tray is removed. Cooperating driving and driven structures, respectively disposed within the housing and on the envelope tray, function to sequentially feed the envelopes in either stack thereof into the printing device housing for passage through its existing printing and paper exit paths.
Patent DE-69202594-T2 (DE)
Inventor: OHMORI SHINJI
IPC: A61K36/062
Filed: 1992-02-22
Granted: 1995-09-28
Abstract: The invention provides an anticataract composition containing a compound of the following formula <CHEM> [wherein Rs are the same or different and each means a hydrogen atom or a lower alkyl group] or a pharmacologically acceptable salt thereof. The anticataract composition of this invention is useful for the prevention and treatment of various types of cataract including senile cataract and diabetic cataract.
Patent DE-69202781-T2 (DE)
Inventor: GRANDVALLET PIERRE
IPC: C07C11/09
Filed: 1992-02-21
Granted: 1995-11-16
Abstract: Process for the conversion of a feedstock comprising linear olefins into a product enriched in branched olefins, which process comprises contacting the feedstock with a tectometallosilicate having a ferrierite crystal structure at an olefin partial pressure of more than 0.5 bar.
Patent DE-69205394-T2 (DE)
Inventor: EGRAZ JEAN-BERNARD
IPC: C09C3/04
Filed: 1992-11-06
Granted: 1996-06-05
Abstract: Grinding aid based on polymers and/or copolymers partially neutralised with magnesium for aqueous suspensions of inorganic materials with a view to pigment applications. Grinding aid consisting of the polymers and/or copolymers which result from the polymerisation and/or copolymerisation of acrylic and/or vinyl monomers comprising acidic groups and in which the active acidic sites are completely or partially neutralised with a degree of neutralisation of the active acidic sites by a neutralising agent providing the magnesium ion ranging from 40 % to 60 %, limits included, and by a neutralising agent providing a monovalent ion being capable of neutralising up to 60 % of the active acidic site of the polymer and/or copolymer. Process for grinding in aqueous suspension, employing the said agent and the aqueous suspensions obtained by the said process and their applications in the field of mass filler, paper coating, paint and plastics.
Patent DE-69210407-T2 (DE)
Inventor: APPLETON WILLIAM
IPC: B29C39/40
Filed: 1992-08-27
Granted: 1996-12-05
Abstract: A mold assembly includes first and second mold sections having respective first and second mold cavity defining surfaces, the first mold cavity defining surface terminating in an encircling peripheral rim and the second mold cavity defining surface terminating in a deformable peripheral annulus disposed at a diameter corresponding to the rim, and cooperating tapers depending from each of the first and second molds for relatively centering the molds.
Patent DE-69211922-T2 (DE)
Inventor: BILLIAU ALFONS JOZEF DENIS ALI
IPC: C12N15/13
Filed: 1992-07-23
Granted: 1997-02-27
Abstract: The invention provides a recombinant DNA-molecule for the expression of a functional Fv-fragment of a desired antibody, directed towards interferon, comprising a homologous promoter sequence, a homologous terminator sequence and dicistronic heterologous DNA-sequence, the cistrons of which encoding the variabel part of a heavy chain (VH) of the desired anti-interferon antibody and the variabel part of a light chain (VK) of the desired anti-interferon antibody, respectively. The recombinant Fv-fragment produced by expressing the recombinant DNA-molecule of the invention in a suitable host can be used to neutralize the biological activity of interferon- GAMMA , which may be harmful for the host. The use of a Fv-fragment reduces the anti-immunoglobulin respons provoked in a host to which foreign immunolgobulins are administered. <IMAGE>
Patent DE-69232517-T2 (DE)
Inventor: BRANTIGAN W
IPC: A61F2/28
Filed: 1992-09-04
Granted: 2003-01-02
Abstract: Surgical prosthetic modular implants used singularly or stacked together are provided to support and fuse together adjacent vertebrae or to totally or partially replace one or more vertebrae in a vertebral column. The implants are rigid annular plugs, dimensionally similar to normal vertebral bodies, have simplified oval or hemi-oval shapes with ridged faces to engage adjacent vertebral bodies to resist displacement and allow bone ingrowth and fusion and to interdigitate with the ridges of an adjacent plug for modular stacking to allow variability of ultimate implant height. The implants can be provided in sets of different thicknesses and are internally grooved to receive an upstanding connecting bar to bind together the individual stacked implants into a stable unit. The annular implants have ample spaces to allow ingrowth of blood capillaries and packing of bone graft and are preferably made of a radiolucent material, preferably biocompatible carbon fiber reinforced polymers or are alternately made of traditional orthopaedic implant materials such as nickel, chromium, cobalt, stainless steel or titanium.
Patent DE-69308404-T2 (DE)
Inventor: JEREMA CHESTER P
IPC: C11D7/32
Filed: 1993-07-07
Granted: 1997-10-23
Abstract: Paint stripper compositions include as essential components: from about 10% to about 50% by weight of d-limonene, from about 50% to about 90% by weight of NMP, and from about 0% to about 10% by weight of a thickener.
Patent DE-69317494-T2 (DE)
Inventor: SAUVAIRE YVES
IPC: A61K49/00
Filed: 1993-09-01
Granted: 1998-11-05
Abstract: Antidiabetic composition, characterised in that it contains as active substance, in the free or combined form, at least one mono- or polyhydroxylated amino acid and/or its lactone forms and its amide derivatives.
Patent DE-69318553-T2 (DE)
Inventor: VERDUIJN JOHANNES
IPC: C01B39/04
Filed: 1993-05-28
Granted: 1998-12-10
Abstract: ZSM-22 zeolite which is particularly pure and whose synthesis does not require the synthesis mixture to be stirred can be produced by the addition to the synthesis mixture of a small quantity e.g. 1000 ppm, of preformed ZSM-22 zeolite seed crystals.
Patent DE-69320773-T2 (DE)
Inventor: LACIVITA ANTONIO
IPC: A61M5/32
Filed: 1993-06-22
Granted: 1999-04-29
Abstract: PCT No. PCT/EP93/01619 Sec. 371 Date May 24, 1994 Sec. 102(e) Date May 24, 1994 PCT Filed Jun. 22, 1993 PCT Pub. No. WO94/01152 PCT Pub. Date Jan. 20, 1994A hypodermic needle provided with a protection device against infection risks, substantially comprising a cap (1), or a hollow member shaped like a cylinder or a truncated cone, with piercing-resistant walls (3) having an inner irregular profile (5), which member can be snap-secured to the base (7) supporting the needle (9), and provided at its base (7) with a resilient element (13) formed like a coil or sheath and exhibiting a marked propelling capability, and with a preferably eccentric hole (17) at the tip (15) thereof.
Patent DE-69323090-T2 (DE)
Inventor: TAMURA KUNIO
IPC: C07D307/79
Filed: 1993-10-18
Granted: 2000-01-27
Abstract: A compound represented by general formula (I) and an intermediate for the synthesis thereof (wherein R<1> represents hydrogen or acyl; R<2> represents lower alkyl; R<3> represents hydrogen or lower alkyl; and R<4>, R<5> and R<6> may be the same or different from one another and each represents hydrogen, optionally substituted alkyl, alkenyl, alkynyl or aryl, or alternatively R<2> and R<4> may be combined together to form a 5-membered ring, and R<5> and R<6> may be combined together to form a cycloalkyl group or a heterocyclic group formed by replacing one or more methylene groups of the cycloalkyl group by oxygen, sulfur or alkyl substituted nitrogen atom(s), provided that when the ring formed by combining R<2> and R<4> together is a benzofuran ring, then R<6> is absent). This compound has a highly selective antioxidant effect and is useful as a remedy for arteriosclerosis, myocardial infarction, and so forth. <CHEM>
Patent DE-69401717-T2 (DE)
Inventor: MUNKHOLM CHRISTIANE
IPC: G01N21/64
Filed: 1994-08-30
Granted: 1997-05-22
Abstract: The invention pertains to a method for generating the fluorescence of polyanionic fluorophores in low dielectric media with fluorescence activation produced by specific quaternary onium compounds. The method may be used for measuring an analyte and may be useful in sensor devices.
Patent DE-69402679-T2 (DE)
Inventor: BRINDLE PHILIP
IPC: C08J7/046
Filed: 1994-01-07
Granted: 1997-07-31
Abstract: This invention relates to elastomeric flexible articles (e.g., film articles) that exhibit enhanced lubricity ("slip") with respect to both dry and damp surfaces, particularly skin or other tissue of the wearer, as compared to similar articles or films that are not treated as described herein. This invention also relates to processes for making such articles or films.
Patent DE-69403067-T2 (DE)
Inventor: SPINU MARIA
IPC: C08F8/14
Filed: 1994-02-03
Granted: 1997-08-21
Abstract: Polyvinyl alcohol esterified by lactic is produced by dissolving polyvinyl alcohol and lactic acid in water, and removing the water by volatilization at a temperature of 75 DEG  C. to 175 DEG  C. The lactic acid esterified polyvinyl alcohol is useful as a molding resin, and in films, fibers and adhesives.
Patent DE-69403503-T2 (DE)
Inventor: WU HUA
IPC: C08F114/18
Filed: 1994-02-10
Granted: 1997-09-18
Abstract: Rotating stirring device, particularly for mixing heterogeneous systems in mechanical stirred reactors, fit to be joined to a drive shaft coaxial with respect to the device rotation axis, which comprises a plurality of extended and substantially C-shaped stirring elements, symmeterically arranged with respect to the rotation axis and joined each other at the respective ends correspondently with the rotation axis. Such a device permits to obtain a very efficient material exchange among different phases, substantially remaining constant with the increase of the volume of the mass put under stirring, and it is also characterized by high mixing homogeneity and particularly low shear stress values.
Patent DE-69409029-T2 (DE)
Inventor: MASAHIRO TSUBONE
IPC: B32B5/18
Filed: 1994-05-27
Granted: 1998-08-13
Abstract: A separable foamed thermoplastic resin laminate sheet comprising a foamed thermoplastic resin sheet and a thermoplastic resin film, wherein the foamed thermoplastic resin sheet has a cellular surface having a plurality of cells which have an average cell size of from 0.005 to 0.5 mm and having a surface smoothness Rmax of from 5 to 200 mu m, and the peel strength between the foamed thermoplastic resin sheet and the thermoplastic resin film is from 5 to 400 g/25 mm width. The resin film is easily strippable from the foamed resin sheet with a reduced scatter in peeling strength, making the formings reusable.
Patent DE-69412079-T2 (DE)
Inventor: STIGSSON LARS
IPC: B01D53/77
Filed: 1994-03-04
Granted: 1999-01-07
Abstract: A method of separating sulphur compounds out of a gas containing carbon dioxide and hydrogen sulphide, in a gas washing system, said gas being obtained by gasification of spent cellulose liquor. According to the invention the gas washing system has a gas-liquid contact zone (5) operating at a pressure exceeding atmospheric pressure as well as a regeneration zone (8) operating at a pressure substantially less than the pressure in the gas-liquid contact zone (5). The carbon dioxide partial pressure in the gas prior to entering the gas-liquid contact zone exceeds 0.2 atm. Furthermore the gas comes into contact with an alkaline absorption liquid in the gas-liquid contact zone, and alkaline liquid containing alkali hydrogen sulphide is withdrawn from the gas-liquid contact zone and transferred to the regeneration zone, in which zone hydrogen sulphide is expelled from said liquid containing alkali hydrogen sulphide and withdrawn in the form of a gas.
Patent DE-69412098-T2 (DE)
Inventor: WELLS ROBERT LEE
IPC: A61K8/23
Filed: 1994-05-05
Granted: 1999-04-01
Abstract: Provides hair conditioning shampoo compositions suitable and safe for frequent (e.g., daily) use and contact with the hair and skin, said compositions comprising: (a) one or more detersive surfactants such as those selected from the group consisting of anionic, nonionic, amphoteric, and zwitterionic surfactants;(b) a nonvolatile hair conditioning agent or combination of nonvolatile hair conditioning agents selected from the group consisting of insoluble silicones, water soluble organic cationic conditioning agents such as cationic surfactants and cationic polymers; and (c) from about 20% to about 99.5%, by weight, water; wherein said composition additionally comprises from about 0.004M to about 0.08M of free polyvalent metal cations. The present invention can provide improved consistency of deposition on the hair for nonvolatile, insoluble silicone and water soluble cationic conditioning agents when the composition is applied using water across a broad range of hardness.
Patent DE-69418060-T2 (DE)
Inventor: SNAKENBORG JOHANNES TONNIS
IPC: C25D1/08
Filed: 1994-12-16
Granted: 1999-08-19
Abstract: PCT No. PCT/NL94/00321 Sec. 371 Date Jun. 21, 1996 Sec. 102(e) Date Jun. 21, 1996 PCT Filed Dec. 16, 1994 PCT Pub. No. WO95/17534 PCT Pub. Date Jun. 29, 1995A screen material is described which is formed by cladding, using electroplating, a structure composed of strands or fibers. The structure may incorporate a knit, woven or nonwoven material or, alternatively, of strands or fibres welded together, wound strands or fibers. The structure may be subjected to a calendering operation. The screen material, after having been provided, if required, with an electrically conductive cladding, is provided with a metal layer in an electroplating operation under conditions in which an overgrowth ratio R greater than 1 is achieved. The invention also describes a method for manufacturing such a screen material which preferably involves making use of an electroplating bath for depositing a metal cladding on a starting material in which a chemical compound is present which increases the overgrowth ratio R. The method can be implemented using a variety of conditions which can lead to an overgrowth ratio R of a desired value.
Patent DE-69420556-T2 (DE)
Inventor: WICKS RICHARD
IPC: G01N33/531
Filed: 1994-05-16
Granted: 2000-03-23
Abstract: A method for detection of cardiac troponin I is described. The method is a sandwich assay employing an antibody specific for cardiac troponin I as one binding partner and troponin C as the other binding partner for cardiac troponin I.
Patent DE-69425828-T2 (DE)
Inventor: CUSSLER L
IPC: C07C323/25
Filed: 1994-05-19
Granted: 2001-02-08
Abstract: PCT No. PCT/IB94/00114 Sec. 371 Date Jan. 17, 1996 Sec. 102(e) Date Jan. 17, 1996 PCT Filed May 19, 1994 PCT Pub. No. WO95/03033 PCT Pub. Date Feb. 2, 1995An osmotic device that, following the imbibement of water vapor, provides for the controlled release of a beneficial agent to an aqueous environment. The device comprises a hydrophilic formulation including a beneficial agent, and if needed, an osmagent, surrounded by a wall. The wall is formed at least in part of a semipermeable hydrophobic membrane having an average pore size between about 0.1  mu m and 30  mu m. The pores are substantially filled with a gas phase. The hydrophobic membrane is permeable to water in the vapor phase and the hydrophobic membrane is impermeable to an aqueous medium at a pressure less than about 100 Pa. The beneficial agent is released, for example, by osmotic pumping or osmotic bursting upon imbibement of sufficient water vapor into the device core. These devices minimize incompatibilities between the beneficial agent and ions (such as hydrogen or hydroxyl) or other dissolved or suspended materials in the aqueous medium, since contact between the beneficial agent and the aqueous medium does not occur until after the beneficial agent is released. This results from the semipermeable membrane's selective permeability for water vapor. In addition, the high water fluxes attendant with these vapor-permeable membranes facilitate the delivery of beneficial agents having low solubilities, and the delivery of high dosages of beneficial agents.
Patent DE-69428696-T2 (DE)
Inventor: STEUER R
IPC: B07C3/00
Filed: 1994-05-24
Granted: 2002-05-08
Abstract: A disposable cuvette through which to pass pulsatile flowing blood. The cuvette has a conduit with two opposed walls having a predetermined separation therebetween that varies with each pulse of the flowing blood. A sealed air pocket damps the variation of the predetermined separation. The conduit is comprised of materials which permit passage therethrough of wavelengths of selected electromagnetic radiation. The radiation is emitted from a photoemitter which, and after passing through the cuvette, is detected by a photodetector. The quantities of detected radiation are operated on by a computer which uses a spectrophotometry technique to derive therefrom a blood constituent concentration value. Preferably, both cuvette and spectrophotometry technique are used during hemodialysis to derive changes in the hematocrit value of the blood of a dialyzed patient, thereby to deduce therefrom changes in the blood volume of the patient during dialysis. The technique enables a clinician to monitor a desired biologic constituent concentration value, such as the hematocrit, oxygen saturation, or oxygen content values by deriving and displaying the same as digital values in real time.
Patent DE-69431423-T2 (DE)
Inventor: TANABE MASAYUKI
IPC: A61K31/35
Filed: 1994-07-20
Granted: 2003-08-07
Abstract: The present invention provides a fruit polyphenol obtained by subjecting unripe fruits of Rosaceae to pressing and/or extraction and then purifying the resulting juice or extract. The present invention further provides an antioxidant, a hypotensive agent, an antimutagenic agent, an antiallergic agent and an anticariogenic agent each comprising, as an effective component, a fruit polyphenol obtained by subjecting unripe fruits of Rosaceae to pressing and/or extraction and then purifying the resulting juice or extract. The fruit polyphenol of the present invention has various physiological activities, for example, an antioxidative activity, an ACE-inhibiting activity, an antimutagenic activity, a hyalulonidase-inhibiting activity and a GTase-inhibiting activity. <IMAGE>
Patent DE-69516268-T2 (DE)
Inventor: DUSSAULT A
IPC: H01R13/66
Filed: 1995-01-13
Granted: 2000-08-31
Abstract: An electrochemical/gas analyzer providing a rugged contact system for removable sensors capable of withstanding inexpert sensor insertion or removal, providing protection for high impedance input electronics against electrostatic discharge (ESD) damage, and providing automatic connection to diagnostic circuitry upon sensor removal has been developed. The contact system includes a plurality of stamped contacts electrically connecting a diagnostic circuit, including a source of diagnostic signals and a ground path, to analyzer signal processing circuitry. Removal of a sensor from this system electrically connects the sensor signal processing electronics to the diagnostic circuit. Insertion of the sensor interrupts electrical connection between the diagnostic circuit and the stamped contact, which connects the sensor terminals to the signal processing circuitry.
Patent DE-69521734-T2 (DE)
Inventor: YAMAMOTO KEIJI
IPC: A61P11/00
Filed: 1995-04-12
Granted: 2001-11-08
Abstract: A percutaneous absorption preparation comprising a support and, formed on one side thereof, a plaster layer comprising a pressure-sensitive adhesive and tulobuterol in an amount not lower than its saturation solubility in the pressure-sensitive adhesive, the tulobuterol contained in the plaster layer consisting of dissolved tulobuterol and crystalline tulobuterol with the ratio of the content of the crystalline tulobuterol to that of the dissolved tulobuterol being from 0.1 to 10.
Patent DE-69524623-T2 (DE)
Inventor: RATTI EMILIANGELO
IPC: A61K45/00
Filed: 1995-10-12
Granted: 2002-08-08
Abstract: The use of CCK-B antagonists for the treatment of sleep disorders.
Patent DE-69524973-T2 (DE)
Inventor: HANULIAK ALOJZ
IPC: E01F8/00
Filed: 1995-11-08
Granted: 2002-11-14
Abstract: For a wasteless elimination of used plastic bottles, the elimination procedure being based on creation of barriers, especially safety barriers, there is designed a panel consisting of resilient hollow columns (13), the columns (13) comprising a pile of tubes (11) furnished with at least one cross baffle (15) and inserted one into the other and assembled, side by side, at least in one row and mutually interconnected into an integral body. The tubes (11) are made of plastic bottles with removed neck pieces (14). The neck piece (14) may be inserted in the bottle body when turned around about 180 DEG  with respect to the original position on the bottle body. The assembly of columns (13) is seated in a casing (20) having elastic walls.